Partner with Experts in Precision Medicine

A global CRO to help you navigate the complexities of therapeutic development and improve health for all.

Watch the video
CellCarta acquires Biogazelle

Expanding our genomic biomarker franchise with the acquisition of Biogazelle, an expert in dPCR, qPCR, and RNAseq assays.

More details
CellCarta acquires Biogazelle
Deep Expertise in Oncology and Immunology

A team of experienced scientists dedicated to advancing your clinical programs.

Learn More
Deep Expertise in Oncology and Immunology
We Understand the Value of Your Samples

Integrated sample management, logistics, and kitting solutions with unique expertise in handling specialty samples.

Learn More
We Understand the Value of Your Samples
AI-Powered Pathology

New generation of AI-Powered Pathology Solutions to improve patient outcomes.

More details
AI-Powered Pathology
Global Presence with Local Expertise

Eleven facilities located in Canada, USA, Belgium, Australia, and China.

More details
Global Presence with Local Expertise
Testing Services
Technologies
Therapeutic Areas
Logistics Services

Latest News and Events

CellCarta Logo

News

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

More info

News

physIQ and CellCarta Collaborate to Accelerate a More Precise, Personalized Approach to Vaccine Development

March 17, 2022

More info
CellCarta Logo

Event

CYTO 2022

Philadelphia, PA

From June 3 2022 to June 7 2022

Book a meeting More info
Biogazelle

News

CellCarta acquires Biogazelle

December 14, 2021

More info
Services
CellEngineTM Software

Cytometry analysis that is faster, more reliable with advanced visualization features

More info
CellEngine<sup>TM</sup> Software
Services
MOSAIC Laboratories – A CellCarta Company

Pioneer in histopathology and multiplex IHC (mIHC) assays

More info
MOSAIC Laboratories – A CellCarta Company
Technology
Olink® PEA Technology

CellCarta offers Olink® Target 96 & Target 48 panels for advanced protein biomarker quantification

More info
Olink® PEA Technology
Therapeutic Area
Oncology

Developing and deploying assays for exploratory, secondary, and primary endpoints to support multitude of oncology programs.

More info
Oncology

Science Hub

Press Releases

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

May 19, 2022

Proteomics/Mass Spectrometry

More info

Scientific Publications

Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

April 12, 2022

More info

Scientific Publications

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

April 1, 2022

More info

Scientific Publications

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

April 1, 2022

More info

Careers

The best scientific minds working together to advance precision medicine

If you are passionate about science, join CellCarta and help shape the future of precision medicine.

See our job opportunities
Brandbourg_Caprion-1335-v2